Reg 74(5) compliance certificate for Q2 FY27 filed with BSE

Compliance View source PDF Explain this filing

JENBURPH · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.7%Reaction day

₹925.05

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%-0.9% vs market

Pharmaceuticals peers, median of 168sector-0.3%-0.4% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 0.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.7+0.2-0.9-0.3-0.4

Next day

+0.3+0.9-0.6-0.3+0.7

-1.0-0.8-0.2-1.2+0.2

-0.5-0.1-0.5-1.0+0.5

-2.1-1.7-0.4-2.6+0.5

-3.8-4.3+0.5-4.0+0.2

-6.0-7.5+1.5-6.5+0.6

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 168Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Jenburkt Pharmaceuticals has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate, issued by Registrar Bigshare Services Pvt Ltd on 7 October 2026, confirms that all share certificates received for dematerialisation were processed, listed, mutilated and cancelled, with the depository name substituted in the register of members within 15 days. This is a routine procedural filing.

Likely market impact

Routine regulatory compliance; no impact on shareholders or stock price.